VIP and Insulin resistance: The altered glucose tolerance of our patient is also related to the effect of VIP high circulating levels, stimulating glucagon release and activating liver glycogenolysis, and to acidosis-mediated insulin resistance development, although a contribution of the modest catecholamines excess cannot be excluded (33, 34).